Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast CancerOlivia Pagani, Prudence A. Francis, Graziella Pinotti et al.|New England Journal of Medicine|2014Cited by 751
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast CancerPrudence A. Francis, Meredith M. Regan, Olivia Pagani et al.|New England Journal of Medicine|2018Cited by 684
Obesity at diagnosis is associated with inferior outcomes in hormone receptor‐positive operable breast cancerJoseph A. Sparano, Nancy E. Davidson, Molin Wang et al.|Cancer|2012Cited by 209
Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT TrialsOlivia Pagani, Prudence A. Francis, Barbara Walley et al.|Journal of Clinical Oncology|2022Cited by 159
Race and Hormone Receptor–Positive Breast Cancer Outcomes in a Randomized Chemotherapy TrialJoseph A. Sparano, Nancy E. Davidson, Μolin Wang et al.|JNCI Journal of the National Cancer Institute|2012Cited by 109